Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.69% |
| 2 | Industrials | 9.96% |
| 3 | Consumer Discretionary | 8.03% |
| 4 | Healthcare | 7.46% |
| 5 | Financials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
PUT
SELLAS Life Sciences
SLS
$3.12B
| $7.38M | 0.01% |
+500,000
| New | +$3.45M |
|
|
ODTX
1152
Odyssey Therapeutics
ODTX
$1.27B
| $7.37M | 0.01% |
+393,862
| New | +$6.91M |
|
|
LADR
1153
Ladder Capital
LADR
$1.26B
| $7.37M | 0.01% |
740,592
+174,951
| +31% | +$1.78M |
|
1154
Green Plains
GPRE
$1.14B
| $7.31M | 0.01% |
475,135
-240,239
| -34% | -$3.82M |
|
1155
NovoCure
NVCR
$1.99B
| $7.27M | 0.01% |
479,999
+468,168
| +3,957% | +$7.08M |
|
1156
CALL
Spotify
SPOT
$110B
| $7.25M | 0.01% |
15,800
-4,500
| -22% | -$2.15M |
|
1157
Essential Properties Realty Trust
EPRT
$6.67B
| $7.22M | 0.01% |
241,916
-2,326,868
| -91% | -$72.3M |
|
1158
Merck
MRK
$376B
| $7.2M | 0.01% |
56,028
-1,756,580
| -97% | -$206M |
|
1159
Elbit Systems
ESLT
$34.7B
| $7.18M | 0.01% |
9,466
+4,110
| +77% | +$3.42M |
|
1160
MakeMyTrip
MMYT
$5.69B
| $7.16M | 0.01% |
134,311
+68,506
| +104% | +$3.12M |
|
1161
Viper Energy
VNOM
$16.3B
| $7.16M | 0.01% |
168,772
-565,987
| -77% | -$26.1M |
|
1162
Vertiv
VRT
$101B
| $7.12M | 0.01% |
21,271
+16,234
| +322% | +$5.15M |
|
|
1163
PUT
Merck
MRK
$376B
| $7.11M | 0.01% |
55,300
-54,800
| -50% | -$6.41M |
|
1164
Deutsche Bank
DB
$71.1B
| $7.08M | 0.01% |
209,622
+126,972
| +154% | +$4.11M |
|
1165
UGI
UGI
$8.06B
| $7.07M | 0.01% |
204,568
-390,627
| -66% | -$13.8M |
|
|
TWO
1166
Two Harbors Investment
TWO
$1.27B
| $7.06M | 0.01% |
568,693
-4,360,728
| -88% | -$52.2M |
|
1167
PUT
AbbVie
ABBV
$468B
| $7.05M | 0.01% |
28,000
+8,300
| +42% | +$1.79M |
|
1168
Vontier
VNT
$4.46B
| $7.04M | 0.01% |
+242,707
| New | +$7.75M |
|
1169
Revvity
RVTY
$13.9B
| $7.02M | 0.01% |
+63,056
| New | +$6.07M |
|
1170
Walt Disney
DIS
$186B
| $7.01M | 0.01% |
72,803
-569,041
| -89% | -$58M |
|
1171
CALL
Target
TGT
$75.1B
| $7M | 0.01% |
53,600
-17,100
| -24% | -$2.17M |
|
1172
Prosperity Bancshares
PB
$8.75B
| $7M | 0.01% |
95,794
+87,550
| +1,062% | +$6.09M |
|
1173
Trex
TREX
$4.77B
| $6.99M | 0.01% |
139,590
-636,664
| -82% | -$26.4M |
|
1174
Kraft Heinz
KHC
$30.3B
| $6.97M | 0.01% |
294,899
-534,336
| -64% | -$12.3M |
|
1175
Rocket Lab Corp
RKLB
$46.4B
| $6.91M | 0.01% |
67,965
+58,025
| +584% | +$5.78M |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.